Evolent Health Shares Outstanding 2014-2026 | EVH
Evolent Health shares outstanding from 2014 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
|
Evolent Health Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025 | 114 |
| 2024 | 115 |
| 2023 | 111 |
| 2022 | 94 |
| 2021 | 86 |
| 2020 | 85 |
| 2019 | 82 |
| 2018 | 77 |
| 2017 | 64 |
| 2016 | 45 |
| 2015 | 46 |
| 2014 | 2 |
| 2013 | 3 |
|
Evolent Health Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2026-03-31 | 112 |
| 2025-12-31 | 114 |
| 2025-09-30 | 114 |
| 2025-06-30 | 116 |
| 2025-03-31 | 115 |
| 2024-12-31 | 115 |
| 2024-09-30 | 115 |
| 2024-06-30 | 115 |
| 2024-03-31 | 114 |
| 2023-12-31 | 111 |
| 2023-09-30 | 112 |
| 2023-06-30 | 111 |
| 2023-03-31 | 108 |
| 2022-12-31 | 94 |
| 2022-09-30 | 99 |
| 2022-06-30 | 90 |
| 2022-03-31 | 90 |
| 2021-12-31 | 86 |
| 2021-09-30 | 86 |
| 2021-06-30 | 85 |
| 2021-03-31 | 85 |
| 2020-12-31 | 85 |
| 2020-09-30 | 85 |
| 2020-06-30 | 85 |
| 2020-03-31 | 85 |
| 2019-12-31 | 82 |
| 2019-09-30 | 84 |
| 2019-06-30 | 82 |
| 2019-03-31 | 79 |
| 2018-12-31 | 77 |
| 2018-09-30 | 78 |
| 2018-06-30 | 77 |
| 2018-03-31 | 75 |
| 2017-12-31 | 64 |
| 2017-09-30 | 70 |
| 2017-06-30 | 59 |
| 2017-03-31 | 53 |
| 2016-12-31 | 45 |
| 2016-09-30 | 43 |
| 2016-06-30 | 43 |
| 2016-03-31 | 42 |
| 2015-12-31 | 46 |
| 2015-09-30 | 41 |
| 2015-06-30 | 37 |
| 2015-03-31 | 3 |
| 2014-12-31 | 2 |
| 2014-09-30 | 3 |
| 2014-06-30 | 2 |
| 2014-03-31 | |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.260B | $1.876B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| Standard BioTools (LAB) | United States | $0.345B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |